Concepedia

Publication | Open Access

Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer

DOIFull Paper Access

109

Citations

27

References

2016

Year

Yuka Asano, Shinichiro Kashiwagi, Wataru Goto, K. Kurata, Satoru Noda, Tsutomu Takashima, Naoyoshi Onoda, S Tanaka, Masahiko Ohsawa, Kosei Hirakawa
British journal of surgery

Abstract

The CFR may be a useful biomarker to predict treatment response to neoadjuvant therapy in aggressive breast cancer subtypes, such as TNBC and HER2BC.

References

YearCitations

Page 1